The EAST syndrome and KCNJ10 mutations

New England Journal of Medicine

Volumn 361, Issue 6, 2009, Pages 630-631

  Shi, Ming ^a   Zhao, Gang ^a  

^a Xijng Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INWARDLY RECTIFYING POTASSIUM CHANNEL; PROTEIN KCNJ10; UNCLASSIFIED DRUG;

APOPTOSIS; CELL DIFFERENTIATION; CLINICAL FEATURE; EAST SYNDROME; GENETIC DISORDER; HUMAN; LETTER; MEMBRANE POTENTIAL; MISSENSE MUTATION; MYELIN DEFICIENCY; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; SEIZURE;

EID: 68249147516     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc091202     Document Type: Letter

References (2)

1. Bockenhauer D, Feather S, Stanescu HC, et al. Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N Engl J Med 2009;360:1960-70.
2. Neusch C, Rozengurt N, Jacobs RE, Lester HA, Kofuji P. Kir4.1 potassium channel subunit is crucial for oligodendrocyte development and in vivo myelination. J Neurosci 2001;21:5429-38.